GlassScriptPhysician profile
Henna M Malik
NPI 1003099813
$360,031.01
in general payments reported to CMS, 2019-2025
80 companies · $92K in 2025
The $92K reported for 2025 was more than what 98% of Medical Oncology providers received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $12K · 2021: $26K · 2022: $53K · 2023: $91K · 2024: $68K · 2025: $92K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $194K · Travel and Lodging: $21K · Consulting Fee: $20K · Food and Beverage: $16K · Education: $241.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $193,992.75 |
| Travel and Lodging | $21,318.67 |
| Consulting Fee | $20,113.00 |
| Food and Beverage | $15,607.00 |
| Education | $241.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $81,622.45 | 2019-2025 | Lynparza, Enhertu, Tagrisso |
| Regeneron Healthcare Solutions, INC. | $72,781.78 | 2021-2025 | Libtayo, Lynozyfic |
| Pharmaessentia USA Corporation | $46,514.21 | 2022-2025 | Besremi |
| Janssen Biotech, INC. | $35,698.14 | 2019-2025 | Rybrevant, Carvykti, Erleada |
| E.R. Squibb & Sons, L.L.C. | $30,780.45 | 2019-2025 | Augtyro, Opdivo, Opdualag |
| Astellas Pharma US INC | $24,200.35 | 2022-2025 | Padcev, Xtandi, Vyloy |
| Genzyme Corporation | $17,703.47 | 2021-2025 | |
| Seagen INC. | $14,366.89 | 2019-2025 | Padcev, Adcetris |
| Array Biopharma INC | $5,171.91 | 2021-2025 | Braftovi, Mektovi, Lorbrena |
| Genentech USA, INC. | $4,156.00 | 2019-2025 | Columvi, Polivy, Lunsumio |
| Celgene Corporation | $3,525.11 | 2019-2025 | Reblozyl, Pomalyst, Opdualag |
| Eisai INC. | $3,466.04 | 2019-2025 | |
| Sirtex Medical INC | $3,209.73 | 2021-2024 | Sir-Spheres Microspheres |
| Regeneron Pharmaceuticals, INC. | $3,111.77 | 2023-2024 | Libtayo |
| Exelixis INC. | $2,643.46 | 2019-2025 | Cabometyx |
Show all 77 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mirati Therapeutics, INC. | $1,934.57 | 2023-2024 | Krazati |
| Pharmacosmos Therapeutics INC. | $1,519.95 | 2021-2025 | Monoferric |
| Bayer Healthcare Pharmaceuticals INC. | $733.43 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $699.20 | 2022-2025 | |
| Pfizer INC. | $648.71 | 2022-2025 | |
| Tempus Ai, INC | $549.13 | 2024-2025 | Xt Cdx |
| Lilly USA, LLC | $489.98 | 2019-2022 | |
| Myriad Genetic Laboratories, INC. | $370.15 | 2022-2024 | Myrisk |
| Glaxosmithkline, LLC. | $290.39 | 2021-2025 | Ojjaara, Blenrep |
| Springworks Therapeutics, INC. | $236.18 | 2024 | Ogsiveo |
| Daiichi Sankyo INC. | $229.24 | 2024-2025 | Enhertu, Vanflyta |
| Jazz Pharmaceuticals INC. | $188.05 | 2024-2025 | |
| Amgen INC. | $175.72 | 2019-2024 | Kyprolis, Blincyto, Lumakras |
| Athenex Pharmaceutical Division, LLC | $175.00 | 2020 | |
| Merck Sharp & Dohme LLC | $159.31 | 2023-2025 | Keytruda, Welireg, Lynparza |
| Abbvie INC. | $148.92 | 2023-2025 | |
| Gilead Sciences, INC. | $144.65 | 2021-2024 | Trodelvy |
| Adc Therapeutics America, INC. | $139.94 | 2024 | |
| Sobi, INC | $136.55 | 2023-2024 | |
| Deciphera Pharmaceuticals INC. | $134.43 | 2022-2025 | Qinlock, Tgct, Romvimza |
| Astrazeneca Uk Limited | $121.99 | 2025 | Calquence |
| Kite Pharma, INC. | $116.67 | 2024-2025 | Yescarta |
| Morphosys, US INC. | $114.78 | 2022-2023 | Monjuvi |
| Beigene USA, INC. | $104.65 | 2023-2025 | Brukinsa |
| Puma Biotechnology, INC. | $98.63 | 2022-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $93.63 | 2019-2020 | |
| Intuitive Surgical, INC. | $92.21 | 2023 | Da Vinci Surgical System |
| Incyte Corporation | $86.35 | 2022-2025 | Monjuvi |
| Beone Medicines USA, INC. | $75.08 | 2025 | Brukinsa |
| Tactile Systems Technology INC | $73.21 | 2022-2023 | Entre Plus, Flexitouch Plus |
| Adaptive Biotechnologies Corporation | $72.66 | 2022-2024 | Clonoseq |
| Emd Serono, INC. | $71.37 | 2023-2024 | Bavencio |
| Fennec Pharmaceuticals, INC. | $60.12 | 2023-2024 | Pedmark |
| Amneal Pharmaceuticals LLC | $50.05 | 2023-2025 | Alymsys, Neulasta, Avastin |
| Tersera Therapeutics LLC | $48.36 | 2023-2024 | Zoladex |
| Dova Pharmaceuticals | $47.18 | 2020 | |
| Taiho Oncology, INC. | $45.64 | 2022-2023 | |
| Rigel Pharmaceuticals, INC. | $40.76 | 2023-2025 | Rezlidhia, Gavreto, Tavalisse |
| Aveo Pharmaceuticals, INC. | $38.42 | 2022-2025 | |
| Stemline Therapeutics INC. | $36.72 | 2023-2025 | Orserdu |
| Ipsen Biopharmaceuticals, INC | $34.29 | 2024 | Onivyde |
| Cti Biopharma Corp. | $32.56 | 2022-2023 | Vonjo |
| Myovant Sciences INC. | $28.45 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.32 | 2019 | |
| Blueprint Medicines Corporation | $27.74 | 2023 | Ayvakit |
| Pharmacyclics LLC, An Abbvie Company | $26.38 | 2023 | Imbruvica, Epkinly |
| Geron Corporation | $25.38 | 2025 | Rytelo |
| Immunocore Limited | $25.37 | 2024 | Kimmtrak |
| Recordati_rare_diseases_inc. | $25.02 | 2025 | Enjaymo |
| Alexion Pharmaceuticals, INC. | $24.29 | 2023 | Ultomiris |
| Inari Medical, INC. | $23.42 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Menarini Silicon Biosystems, INC. | $21.18 | 2024 | |
| Karyopharm Therapeutics INC. | $21.14 | 2022 | |
| Verity Pharmaceuticals INC. | $20.57 | 2023 | Trelstar |
| Tolmar Pharmaceuticals, INC. | $20.44 | 2022 | |
| Kyowa Kirin, INC. | $19.91 | 2023 | Poteligeo |
| Legend Biotech USA INC. | $17.07 | 2024 | |
| Agios Pharmaceuticals, INC. | $15.98 | 2025 | Pyrukynd |
| Foundation Medicine, INC. | $14.93 | 2019 | |
| Boston Scientific Corporation | $13.48 | 2023 | Therasphere Y90 Glass Microspheres 10 Gbq |
| Clovis Oncology, INC. | $10.80 | 2019 | |
| Iovance Biotherapeutics, INC. | $10.55 | 2025 | Amtagvi |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Henna Malik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.